Blood test study to match cancer patients to treatment
Part of Cancer clinical trials.
This study collects a small amount of your blood to analyze cancer signals and sort patients by cancer “size and stage.” The goal is to see whether this blood-based information can help guide cancer care more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be able and willing to sign informed consent
- Be able to have 35–40 mL of whole blood drawn (about a few tablespoons)
- If you have ever had cancer, only non-melanoma skin cancer is allowed
- Do not have had cancer treatment (surgery, radiation, or medicine) before joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a blood-based test that looks at “RNA signals” can detect cancer. If you qualify, you may have extra blood taken to help test how accurate the method is.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This trial looks at the tumor’s DNA to help doctors choose the best next treatment for people with advanced cancer. It’s testing whether this “exome” genetic analysis can improve therapeutic decisions for newly treated metastatic or locally advanced solid tumors.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This trial studies a blood test that looks for circulating tumor markers in people with any type of invasive cancer (newly diagnosed or suspected). The goal is to see if markers in the blood can help monitor the cancer and guide treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.